Skip to content
#diffusion models Open access

Cross-modality network phenotyping: a multivariate MRI biomarker signature predicts spatial pathology and clinical severity in EAE

Sep 2026 · Frontiers in Neurology · Vol 17 · 0 citations · 35 references
Medicine

TL;DR

An automated, spatially targeted multiparametric magnetic resonance imaging (MRI) pipeline to extract highly specific in vivo biophysical markers and benchmarked its performance against a potent positive control immunomodulator, fingolimod, provides an objective, continuous metric that complements traditional tissue assays, enhancing the evaluation of multiple sclerosis therapeutics while advancing the reduction of animal use.

Abstract

Introduction Evaluating novel therapies for multiple sclerosis requires robust, non-invasive biomarkers. In the experimental autoimmune encephalomyelitis (EAE) model, standard disease evaluations rely heavily on subjective clinical motor scoring and terminal histology, which frequently suffer from a mathematical dilution effect. To address this, we developed an automated, spatially targeted multiparametric magnetic resonance imaging (MRI) pipeline to extract highly specific in vivo biophysical markers and benchmarked its performance against a potent positive control immunomodulator, fingolimod. Methods EAE was induced in mice using a myelin oligodendrocyte glycoprotein peptide, followed by treatment with either vehicle or fingolimod. At 28 days post-induction, in vivo T2-weighted and diffusion tensor imaging maps of the lumbar spinal cord were acquired and segmented into specific gray and white matter columns. The extracted MRI parameters were cross-correlated with clinical scores, spatial histopathology, and flow cytometry. Results Vehicle-treated mice exhibited severe elevations in gray matter T2 relaxation times and precipitous drops in white matter fractional anisotropy, structurally mapping to localized edema, demyelination, and dense cellular infiltrates. Fingolimod treatment successfully rescued these structural deficits, alongside clinical motor deficits and T-cell infiltration. Localized metrics, specifically ventral white matter fractional anisotropy and a composite fractional anisotropy to T2 ratio, demonstrated treatment effect sizes that exceeded those of the gross clinical paralysis score and corresponding lumbar histopathology. Multivariate predictive modeling showed that the combined MRI panel predicted up to 87.2% of the variance in regional spinal cord pathology and 80.1% of the variance in clinical paralysis. Furthermore, unsupervised principal component analysis extracted an MRI disease score that strongly correlated with clinical disability, global histopathology, and total central nervous system T-cells. Conclusion Spatially targeted, multiparametric MRI serves as a highly sensitive, objective surrogate biomarker signature. By overcoming the dilution effect, this non-invasive approach provides an objective, continuous metric that complements traditional tissue assays, enhancing the evaluation of multiple sclerosis therapeutics while advancing the reduction of animal use.

Read PDF

Similar papers

Sep 2026

Imaging subtypes reveal distinct biological substrates and disability profiles in multiple sclerosis.

Multimodal MRI analysed with SuStaIn identified reproducible subtypes of multiple sclerosis with clinically meaningful differences in phenotype, age at onset, disability, and relapse-independent progression, while cognitive impairment was related to advancing SuStaIn stage within each subtype.

P. Preziosa, L. Storelli, F. Clarelli et al. · 0 citations
Open access Oct 2026

Diffusion Basis Spectrum Imaging of Tissue Microstructure and Early Treatment in Multiple Sclerosis

ABSTRACT Objective Conventional MRI cannot resolve the coexisting pathological processes within multiple sclerosis tissue. Diffusion Basis Spectrum Imaging decomposes the diffusion signal into fiber, cell, and hindered ratios indexing axonal integrity, cellularity, and extracellular space, respectively. We asked how th...

Apisit Kaewsanit, Aime Luna, Bradley Judge et al. · 0 citations
#diffusion models Open access Oct 2026

Quantitative, longitudinal measurements of response to immunotherapy for glioblastoma using multiparametric MRI in a long-term survivor treated with autologous tumor lysate–loaded dendritic cell vaccine: an illustrative case

Neurosurgeons are in the forefront of developing clinical trials that harness the immune system to combat glioblastoma. Autologous tumor lysate–loaded dendritic cell vaccine (DCVax-L) is a novel immunotherapy for glioblastoma. An unmet need is to develop a sensitive, specific, feasible, clinically relevant, neuroim...

Archith Rajan, Steven Brem, D. Gewolb et al. · 0 citations
Open access Aug 2026

Detection of Lipid-Mediated Diffused Pathological Changes in Multiple Sclerosis

Reduced tNOE contrast corresponded with known regional differences in myelin density and suggests sensitivity to myelin-integrity, and shows promise as a rapid biomarker for MS diagnosis.

Blake Benyard, Dushyant Kumar, Neil E. Wilson et al. · 0 citations
#diffusion models Open access Sep 2026

Multimodal Magnetic Resonance Imaging and Machine Learning Uncovers Distinct Progression Patterns in Friedreich Ataxia.

Longitudinal multimodal MRI shows distinct neurodegenerative progression patterns in FRDA that are not fully captured by conventional clinical measures, and provides a basis for investigating imaging-derived disease heterogeneity and its potential relevance to participant stratification in clinical trials.

Susmita Saha, N. Georgiou-Karistianis, Vivienne Teo et al. · 0 citations

Related blog posts

Microsoft Research Blog Nov 16, 2026

TokenEconomizer: Learning from Experience to Make AI Coding Agents More Efficient

AI coding agents are increasingly help developers fix bugs and build features largely on their own, but every interaction with their models consumes tokens. In each session, an agent sends instructions, tool descriptions, and session history to its model. Most efforts to reduce this cost focus on individual tasks. Yet developers return to the same […] The post TokenEconomizer: Learning from Experience to Make AI Coding Agents More Efficient appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.